Customize
Quick Links
Specialties

Accreditation/Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Genomic Health, Inc., Illumina, Inc., Lilly, and Novartis Pharmaceuticals Corporation.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Community Practice Connections™: 1st Annual International Congress of Oncology Pathology™: Towards Harmonization of Pathology and Oncology Standards

Release Date: August 31, 2017
Expiration Date: August 31, 2018
Media: Internet - based

 

Activity Overview

Community Practice Connections™: 1st Annual International Congress of Oncology Pathology (ICOP)™: Towards Harmonization of Pathology and Oncology Standards is a continuing medical education (CME)-certified activity based on a symposium of the same name held in New York, NY, on June 24, 2017.

ICOP was developed to bring together oncologists and pathologists to facilitate awareness of recent advancements in the field of cancer pathology and enhance multidisciplinary collaboration. The live portion of the activity provided a review of the latest information on key topics in cancer pathology that can readily be applied to clinical practice in a variety of settings. Leading experts addressed critical topics in pathology screening for malignancies commonly encountered in clinical practice. From a foundation of tumor-specific discussions, our clinical experts reviewed clinical guidelines, explored new concepts and clinical research, and addressed obstacles to optimizing practice.

This interactive, online CME activity is based on the presentations that took place during the ICOP meeting, and includes additional interviews with 3 of the distinguished ICOP faculty members, including both meeting chairs, exploring clinically relevant questions from the community clinician perspective. Important topics addressed in this activity include:

  • Recent advancements in clinical testing for commonly-encountered malignancies
  • Clinical considerations for genomic and targeted assays
  • Recent clinical trial data for commonly-encountered malignancies that may help to tailor patient treatment approaches
  • Molecular and cytogenetic testing applications
  • Advancements in the understanding of the immunogenicity of commonly-encountered malignancies
  • Strategies to optimize patient outcomes through multidisciplinary collaboration

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Genomic Health, Inc., Illumina, Inc., Lilly, and Novartis Pharmaceuticals Corporation.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

CME/CE Activity Table of Contents

  • Module 1. Tissue, Issues, and Looking Toward the Horizon
  • Module 2. Patient Selection for Immunotherapy: To PD-L1 and Beyond
  • Module 3. The ABCs of Lung Cancer Management

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a cme/ce certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a cme/ce certificate upon completion of these steps.

Target Audience

This educational activity is directed toward pathologists and oncologists interested in the management of patients with cancer. Fellows, residents, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of patients with cancer are also invited to participate.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Describe recent advancements in the understanding of the pathogenesis and relevant biomarkers of commonly-encountered malignancies
  • Select evidence-based molecular and cytogenetic testing strategies for commonly-encountered malignancies
  • Compare the roles of genomic and targeted assays in patient management
  • Develop multidisciplinary strategies to optimize cancer diagnosis and management
  • Apply current clinical trial data in cancer pathology to the tailoring of patient treatment protocols

Faculty, Staff, and Planners' Disclosures

Chairs

Alain Borczuk, MD
Professor of Pathology and Laboratory Medicine
Vice Chairman for Anatomic Pathology
Department of Pathology and Laboratory Medicine
Weill Cornell Medicine
New York, NY

Disclosure: None.

Balazs Halmos, MD, MS
Professor of Clinical Medicine
Director, Thoracic Oncology
Director, Clinical Cancer Genomics
Albert Einstein College of Medicine/Montefiore Medical Center
Bronx, NY

Disclosure: Grant Research Support: Eli-Lilly, Novartis, Mirati, Ariad, Merck, Boehringer-Ingelheim, Astra-Zeneca,Pfizer, Genentech, Astra-Zeneca; Consultant: Pfizer, Genentech, Astra-Zeneca, Boehringer-Ingelheim, Foundation One

Faculty

Charles G. Drake, MD, PhD
Director Genitourinary Oncology
Co-Director Immunotherapy Program
Associate Director, Herbert Irving Comprehensive Cancer Center
Columbia University Medical Center, Division of Hematology /Oncology
New York, NY

Disclosure: Grant Research Support: Bristol-Myers Squibb, Janssen, Aduro Biotech; Conulstant: Agenus, Dendreon, NexImmune, ImmunExcite, Janssen, Lilly, Merck, Pierre Fabre, Roche/Genentech; Patents: AZ Medimmune, Bristol-Myers Squibb, Janssen.

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

CME/CE Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
info@gotoper.com

Hardware And Software Requirements 

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Related CME Activites






Become a Member

Forgot Password?
Filter By